|
Design and Development of Innovative Formulations of Resatorvid for Targeted Skin Drug Delivery and Applications Therein
University of Arizona researchers have developed a novel formulation of Resatorvid, a selective TLR4 inhibitor that was originally designed for the treatment of sepsis. This re-formulation is designed for delivery to the skin for a variety of skin diseases including early stages of skin cancer.
Background:
Skin cancers tend to be slow growing and can...
Published: 4/9/2026
|
Updated: 8/3/2020
|
Inventor(s): Sally Dickinson, Victor Ruiz, Heidi Mansour, Clara Curiel, Hsiao-Hui Chow, Georg Wondrak
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Life Sciences > Therapeutics
|
